Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam toluenesulfonate for anesthesia in elderly patients undergoing laparoscopic surgery
ChiCTR2000039392Phase 4Recruiting
- Sponsor
- Tangshan Central Hospital
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam (4 arms), sponsored by Tangshan Central Hospital. Primary endpoints: Mean arterial pressure, heart rate, oxygen saturation, and bispectral index, Induction duration and intubation time and 1 more. Started Oct 2020; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2000039392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039392.